Sumatriptan Tablet
Product Images NDC 68788-6769

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68788-6769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan at strengths 25 mg, 50 mg, and 100 mg, compared to placebo. The graph tracks response probability increasing from 0% to near 80-90% over 240 minutes.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph depicting the estimated probability of headache pain relief over time in hours from initial dose for various doses of sumatriptan (25 mg, 50 mg, 100 mg) compared to placebo. The y-axis shows probability percentages from 0% to 100%, and the x-axis shows time up to 24 hours, illustrating dose-dependent differences in relief response.*

FDA Label Image

Sumatriptan Succinate Tablets, Usp 25mg (Sumatriptan Fig3)

Label for Sumatriptan Succinate Tablets, USP 25 mg, oral tablets by Preferred Pharmaceuticals Inc. The label includes directions for use in English and Spanish, manufacturer information (Aurobindo Pharma Limited), and warnings. It states the product is generic for Imitrex and provides space for lot, batch, expiration date, and prescription details.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate, showing the molecular arrangement including indole and sulfonamide groups along with the succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.